These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37315243)

  • 1. [Acetylsalicylic acid in primary and secondary prevention of atherosclerotic cardiovascular disease].
    Oynotkinova OS; Matskeplishvili ST; Maslennikova OM; Pavlov AI; Poberezhskaya AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):58-64. PubMed ID: 37315243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acetylsalicylic acid in the prevention and treatment of cardiovascular diseases].
    Łabuz-Roszak B; Horyniecki M; Łącka-Gaździk B
    Wiad Lek; 2018; 71(8):1608-1614. PubMed ID: 30684348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of acetylsalicylic acid by physicians and in the community.
    Mahon J; Steel K; Feagan BG; Laupacis A; Pederson LL
    CMAJ; 1991 Nov; 145(9):1107-16. PubMed ID: 1751930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of chronic non-communicable diseases and acetylsalicylic acid: ambiguity of opinions].
    Larina VN; Gaydina TA; Mkrtychev DS; Kuznetsova VA; Snezhko ZV
    Kardiologiia; 2020 Mar; 60(3):96-101. PubMed ID: 32375621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current opportunities for secondary prevention of atherothrombotic stroke].
    Maksimova MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):97-105. PubMed ID: 34481444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylsalicylic acid in primary prevention of cardiovascular disease].
    Miklík R; Jiravský O
    Vnitr Lek; 2022; 68(4):240-245. PubMed ID: 36220422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Prevention of CVD with Aspirin: Benefits vs Risks.
    Weisman SM; Brunton S
    J Fam Pract; 2021 Jul; 70(6S):S41-S46. PubMed ID: 34432623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease.
    Coppens M; Weitz JI; Eikelboom JWA
    Circ Res; 2019 Feb; 124(3):416-425. PubMed ID: 30702997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70).
    Sugawara M; Goto Y; Yamazaki T; Teramoto T; Oikawa S; Shimada K; Uchiyama S; Ando K; Ishizuka N; Murata M; Yokoyama K; Uemura Y; Ikeda Y;
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):299-311. PubMed ID: 30565155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family practice patients' use of acetylsalicylic acid for cardiovascular disease prevention.
    Kolber M; Sharif N; Marceau R; Szafran O
    Can Fam Physician; 2013 Jan; 59(1):55-61. PubMed ID: 23341662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD.
    Meves SH; Hummel T; Endres HG; Mayböck N; Kaiser AF; Schröder KD; Rüdiger K; Overbeck U; Mumme A; Mügge A; Neubauer H
    J Thromb Thrombolysis; 2014; 37(2):190-201. PubMed ID: 23553246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    Dehmer SP; O'Keefe LR; Evans CV; Guirguis-Blake JM; Perdue LA; Maciosek MV
    JAMA; 2022 Apr; 327(16):1598-1607. PubMed ID: 35471506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.
    Bliden KP; Patrick J; Pennell AT; Tantry US; Gurbel PA
    Future Cardiol; 2016 Jan; 12(1):45-58. PubMed ID: 26356085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk.
    Moberg C; Naesdal J; Svedberg LE; Duchateau D; Harte N
    Patient; 2011; 4(2):103-13. PubMed ID: 21766899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incremental cost-effectiveness of dipyridamole + acetylsalicylic acid in secondary prevention of ischemic noncardioembolic stroke].
    Claes C; Mittendorf T; Grond M; von der Schulenburg JM
    Med Klin (Munich); 2008 Nov; 103(11):778-87. PubMed ID: 19165429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    ; Davidson KW; Barry MJ; Mangione CM; Cabana M; Chelmow D; Coker TR; Davis EM; Donahue KE; Jaén CR; Krist AH; Kubik M; Li L; Ogedegbe G; Pbert L; Ruiz JM; Stevermer J; Tseng CW; Wong JB
    JAMA; 2022 Apr; 327(16):1577-1584. PubMed ID: 35471505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.